Cancer Associated Optic Neuropathy

Cancer-associated optic neuropathy (CAON) emerges as a rare but significant challenge in cancer research, characterized by tumors encroaching upon or compressing the optic nerve, leading to vision impairment. Typically observed in advanced cancer stages, especially with metastases or tumors proximal to the optic nerve pathway, CAON presents symptoms ranging from visual disturbances to profound vision loss. Effectively addressing CAON demands a multifaceted approach in cancer research, emphasizing early detection methods and innovative interventions to safeguard optic nerve integrity and preserve visual function. As researchers delve deeper into understanding its mechanisms and refining diagnostic tools, they strive to offer timely interventions, enhancing the quality of life for those affected by CAON amidst their battle against cancer.